773 related articles for article (PubMed ID: 28477681)
1. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
Petrou M; Davatzikos C; Hsieh M; Foerster BR; Albin RL; Kotagal V; Müller ML; Koeppe RA; Herman WH; Frey KA; Bohnen NI
Acad Radiol; 2016 May; 23(5):577-81. PubMed ID: 26874576
[TBL] [Abstract][Full Text] [Related]
4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
5. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
7. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
[TBL] [Abstract][Full Text] [Related]
8. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
[TBL] [Abstract][Full Text] [Related]
9. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
[TBL] [Abstract][Full Text] [Related]
10. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
[TBL] [Abstract][Full Text] [Related]
11. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
12. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
13. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
14. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
[TBL] [Abstract][Full Text] [Related]
15. White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
Rektor I; Svátková A; Vojtíšek L; Zikmundová I; Vaníček J; Király A; Szabó N
PLoS One; 2018; 13(1):e0187939. PubMed ID: 29304183
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
[TBL] [Abstract][Full Text] [Related]
17. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
Chen HM; Zhang MM; Wang YL
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
[No Abstract] [Full Text] [Related]
18. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
19. Freezing of gait in Parkinson's disease: gray and white matter abnormalities.
Pietracupa S; Suppa A; Upadhyay N; Giannì C; Grillea G; Leodori G; Modugno N; Di Biasio F; Zampogna A; Colonnese C; Berardelli A; Pantano P
J Neurol; 2018 Jan; 265(1):52-62. PubMed ID: 29128929
[TBL] [Abstract][Full Text] [Related]
20. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
